Watch Video
Share
December 24, 2021
Merck's Covid-19 pill was cleared by U.S. regulators, giving high-risk patients a second at-home treatment just as the omicron variant is causing cases to surge around the country. Bloomberg's John Lauerman has more on "Bloomberg Markets: The Close."
#bloomberg
Posts